Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 23rdDecember 2014
Summary The industry analysis specialist, has released its new report, “Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Social Anxiety Disorders (SAD) Therapeutics market. The report identifies the key trends shaping and driving the global Social Anxiety Disorders (SAD) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Social Anxiety Disorders (SAD) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-social-anxiety-disorders-sad-therapeutics-pipeline-assessment-andmarket-forecasts-135215
Scope Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
The report provides information on the key drivers and challenges of the Social Anxiety Disorders (SAD) Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Social Anxiety Disorders (SAD) Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Social Anxiety Disorders (SAD) Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Social Anxiety Disorders (SAD) Therapeutics market. - Analysis of key recent licensing and partnership agreements in Social Anxiety Disorders (SAD) Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Social Anxiety Disorders (SAD) Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Social Anxiety Disorders (SAD) Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Social Anxiety Disorders (SAD) Therapeutics market landscape? – Identify, understand and capitalize.
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Social Anxiety Disorders (SAD) Therapeutics - Introduction 2.1 Overview 2.1.1 Types of SAD 2.2 Etiology and Pathophysiology 2.3 Epidemiology 2.3.1 The US 2.3.2 Spain 2.3.3 Italy 2.3.4 Japan 2.3.5 Germany 2.3.6 France 2.3.7 Pharmaco-economic Burden Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.3.8 Quality of Life (QoL) 2.3.9 Morbidity 2.4 Symptoms 2.5 Diagnosis 2.5.1 Diagnostic Criteria for SAD Defined by DSM-IV 2.5.2 Measurement Scales 2.6 Treatment and Management Pattern 2.6.1 Psychological Treatment 2.6.2 Pharmacologic Treatment 2.7 Referral Pathway 2.8 GlobalData Pipeline Report Guidance 3 SAD Therapeutics - Market Characterization 3.1 Overview 3.2 SAD Therapeutics Market Size (2006-2011) - Global 3.3 SAD Therapeutics Market Forecast (2011-2019) - Global 3.4 SAD Therapeutics Market Size (2006-2011) - The US 3.5 SAD Therapeutics Market Forecast (2011-2019) - The US 3.6 SAD Therapeutics Market Size (2006-2011) - France 3.7 SAD Therapeutics Market Forecast (2011-2019) - France 3.8 SAD Therapeutics Market Size (2006-2011) - Germany 3.9 SAD Therapeutics Market Forecast (2011-2019) - Germany 3.10 SAD Therapeutics Market Size (2006-2011) - Italy 3.11 SAD Therapeutics Market Forecast (2011-2019) - Italy 3.12 SAD Therapeutics Market Size (2006-2011) - Spain 3.13 SAD Therapeutics Market Forecast (2011-2019) - Spain 3.14 SAD Therapeutics Market Size (2006-2011) - The UK 3.15 SAD Therapeutics Market Forecast (2011-2019) - The UK 3.16 SAD Therapeutics Market Size (2006-2011) - Japan 3.17 SAD Therapeutics Market Forecast (2011-2019) - Japan 3.18 Drivers and Barriers 3.18.1 Drivers for the SAD Therapeutics Market 3.18.2 Barriers for the SAD Therapeutics Market 3.19 Opportunity and Unmet Needs 3.20 Key Takeaway 4 SAD Therapeutics Market - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profile for the Major Marketed Products in the SAD Therapeutics Market 4.3.1 SSRIs Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
4.3.2 SNRIs 4.3.3 Benzodiazepines 4.3.4 Monoamine Oxidase Inhibitors 4.4 Key Takeaway 5 SAD Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Pipeline by Phases of Development 5.3.1 SAD Therapeutics-Phase II Pipeline 5.3.2 SAD Therapeutics- Phase I Pipeline 5.4 SAD Therapeutics Market - Clinical Pipeline by Mechanism of Action. 5.5 Technology Trends Analytic Framework 5.6 Promising Drugs under Clinical Development 5.7 Profiles of Promising Drugs 5.7.1 CXB722 5.7.2 PH94B 5.7.3 TGW00AA 5.8 Key Takeaway 6 SAD Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Trial Status 6.4 Prominent Sponsors 6.5 Top Companies Participating in Therapeutics Clinical Trials 7 SAD Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 SAD Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 CeNeRx BioPharma 8.2.2 Fabre-Kramer Pharmaceuticals, Inc 8.2.3 Pherin Pharmaceuticals 8.3 Other Companies in the SAD Therapeutics Market 9 SAD Therapeutics - Licensing and Partnership Deals 10 Appendix 10.1 Market Definitions 10.2 Abbreviations 10.3 Methodology Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
List Of Tables Table 1: FDA and EMEA Approved Medications for the Treatment of SAD Table 2: SAD Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 3: SAD Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 4: SAD Therapeutics Market, The US, Revenue ($m), 2006-2011 Table 5: SAD Therapeutics Market, The US, Forecast ($m), 2011-2019 Table 6: SAD Therapeutics Market, France, Revenue ($m), 2006-2011 Table 7: SAD Therapeutics Market, France, Forecast ($m), 2011-2019 Table 8: SAD Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 9: SAD Therapeutics Market, Germany, Forecast ($m), 2011-2019 Table 10: SAD Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 11: SAD Therapeutics Market, Italy, Forecast ($m), 2011-2019 Table 12: SAD Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 13: SAD Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 14: SAD Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 15: SAD Therapeutics Market, The UK, Forecast ($m), 2011-2019 Table 16: SAD Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 17: SAD Therapeutics Market, Japan, Forecast ($m), 2011-2019 Table 18: Treatment-Emergent Adverse Event Incidence in Short-Term Placebo-Controlled Effexor XR Clinical Trials in SAD Patients Table 19: SAD Therapeutics-Phase II Pipeline Table 20: SAD Therapeutics-Phase I Pipeline Table 21: SAD Therapeutics - Most Promising Drugs Under Clinical Development, 2011 Table 22: SAD Therapeutics Market, Number of Clinical Trials by Region, 2011 Table 23: SAD Therapeutics Market, Global, Clinical Trials by Phase of Development (%), 2011 Table 24: SAD Therapeutics Market, Global, Clinical Trials by Trial Status (%), 2011 Table 25: SAD Therapeutics Market, Global, Clinical Trials by Prominent Sponsors (%), 2011 Table 26: SAD Therapeutics Market, Global, Number of Clinical Trials by Top Companies, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 27: CeNeRx BioPharma - CNS Pipeline Products, 2011 Table 28: CeNeRx BioPharma - SAD Pipeline Products, 2011 Table 29: Fabre-Kramer Pharmaceuticals - CNS Pipeline Products, 2011 Table 30: Fabre-Kramer Pharmaceuticals - SAD Pipeline Products, 2011 Table 31: Pherin Pharmaceuticals - CNS Pipeline Products, 2011 Table 32: Pherin Pharmaceuticals - SAD Pipeline Products, 2011 Table 33: SAD Therapeutics Market - Future Players, 2011 Table 34: SAD Therapeutics, Global, Deals, 2009-2011
List Of Figures Figure 1: SAD Treatment Options Figure 2: Referral Pathway for SAD Figure 3: SAD Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 4: SAD Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 5: SAD Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 6: SAD Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 7: SAD Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 8: SAD Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 9: SAD Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 10: SAD Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 11: SAD Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 12: SAD Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 13: SAD Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 14: SAD Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 15: SAD Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 16: SAD Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 17: SAD Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 18: SAD Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 19: Opportunity and Unmet Need in the SAD Therapeutics Market, 2011 Figure 20: Strategic Competitor Assessment of the Major Marketed Products in SAD, 2011 Figure 21: SAD Therapeutics Pipeline by Phases of Clinical Development (%), 2011 Figure 22: SAD Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2011 Figure 23: Technology Trends Analytic Framework of the SAD Therapeutics Pipeline, 2011 Figure 24: Technology Trends Analytic Framework of the SAD Therapeutics Pipeline Description, 2011 Figure 25: CXB722 Clinical Trial Details Figure 26: PH94B Clinical Trial Details Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 27: TWG00AA Clinical Trial Details Figure 28: SAD Therapeutics Market, Number of Clinical Trials by Region, 2011 Figure 29: SAD Therapeutics Market, Global, Clinical Trials by Phase of Development (%), 2011 Figure 30: SAD Therapeutics Market, Global, Clinical Trials by Trial Status (%), 2011 Figure 31: SAD Therapeutics Market, Global, Clinical Trials by Overall Sponsors (%), 2011 Figure 32: SAD Therapeutics Market, Global, Clinical Trials by Prominent Sponsors (%), 2011 Figure 33: SAD Therapeutics Market, Global, Number of Clinical Trials by Top Companies, 2011 Figure 34: SAD Therapeutics Market, Drivers and Restraints, 2011 Figure 35: Implications for Future Market Competition in the SAD Therapeutics Market, 2011 Figure 36: SAD Therapeutics Market, Clinical Pipeline by Company, 2011 Figure 37: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Waldenstrms Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019 Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-social-anxietydisorders-sad-therapeutics-pipeline-assessment-and-market-forecasts-135215
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/